Inventor
HARRISON TIMOTHY
GB75 patents
⚠️ This page may combine multiple inventors who share the name “HARRISON TIMOTHY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
36 patentsUS6756511B2Jun 29, 2004
Gamma-secretase inhibitors
MERCK SHARP & DOHME83 citations96
US5459270AOct 17, 1995
Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
MERCK SHARP & DOHME69 citations96
US5620989AApr 15, 1997
4-Arylmethyloxymethyl piperidines as tachykinin antagonsits
MERCK SHARP & DOHME61 citations94
US6060469AMay 9, 2000
Spiro-piperidine derivatives and their use as tachykinin antagonists
MERCK SHARP & DOHME42 citations93
US7183303B2Feb 27, 2007
Gamma-secretase inhibitors
MERCK SHARP & DOHME33 citations92
US6579875B1Jun 17, 2003
Triazolo-pyridazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME22 citations92
US6114315ASep 5, 2000
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
MERCK SHARP & DOHME26 citations92
US5977104ANov 2, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME29 citations92
US5952315ASep 14, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME34 citations92
US5728695AMar 17, 1998
Spiroketal derivatives, compositions containing them and their use as therapeutic agents
MERCK SHARP & DOHME26 citations92
US7138400B2Nov 21, 2006
Sulfamides as gamma-secretase inhibitors
MERCK SHARP & DOHME32 citations91
US7101895B2Sep 5, 2006
Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
MERCK SHARP & DOHME39 citations91
US6872731B2Mar 29, 2005
Imidazo-pyridine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME23 citations91
US5612337AMar 18, 1997
Substituted morpholine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME46 citations91
US6890956B2May 10, 2005
Cyclohexyl sulphones as gamma-secretase inhibitors
MERCK SHARP & DOHME56 citations90
US6133255AOct 17, 2000
Tricyclic pyridone analogues as GABA-A receptor ligands
MERCK SHARP & DOHME29 citations89
US6984663B2Jan 10, 2006
Cyclohexyl sulphones
MERCK SHARP & DOHME11 citations83
US6828322B2Dec 7, 2004
Triazolo-pyridazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME14 citations83
US6200982B1Mar 13, 2001
Substituted 1H-pyridinyl-2-ones as GABAA-α 2/3 ligands
MERCK SHARP & DOHME16 citations83
US7105509B2Sep 12, 2006
Benzodiazepine derivatives as APP modulators
MERCK SHARP & DOHME21 citations82
US8362075B2Jan 29, 2013
Cyclohexyl sulphones for treatment of cancer
MERCK SHARP & DOHME9 citations79
US6303605B1Oct 16, 2001
Triazolo-pyridazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME12 citations74
US6271230B1Aug 7, 2001
Use of NK-1 receptor antagonists for treating cognitive disorders
MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000
Spiro-piperidine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999
Use of NK-1 receptor antagonists for treating movement disorders
MERCK SHARP & DOHME7 citations74
US5922744AJul 13, 1999
Ethane-1-2-diamine derivatives and tachykinin antagonists
MERCK SHARP & DOHME13 citations74
US5824678AOct 20, 1998
Morpholine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME11 citations74
US5807865ASep 15, 1998
3,3-disubstituted piperidine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME14 citations74
US6319924B1Nov 20, 2001
Triazolo-pyridazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME13 citations73
US6291460B1Sep 18, 2001
Triazolo-pyridazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME12 citations73
US6100256AAug 8, 2000
Use of NK-1 receptors antagonists for treating schizophrenic disorders
MERCK SHARP & DOHME7 citations73
US5719149AFeb 17, 1998
Morpholine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME8 citations73
US7304094B2Dec 4, 2007
Cyclohexyl sulphones
MERCK SHARP & DOHME7 citations72
US7282513B2Oct 16, 2007
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
MERCK SHARP & DOHME7 citations72
US7205434B2Apr 17, 2007
Sulphonamides for control of beta-amyloid production
MERCK SHARP & DOHME8 citations72
US7041689B2May 9, 2006
Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
MERCK SHARP & DOHME7 citations72
MERCK & CO INC
6 patentsUS5719147AFeb 17, 1998
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC193 citations99
US5637699AJun 10, 1997
Process for preparing morpholine tachykinin receptor antagonists
MERCK & CO INC85 citations96
US6235735B1May 22, 2001
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC19 citations93
US6048859AApr 11, 2000
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC26 citations93
US5872116AFeb 16, 1999
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC14 citations74
US6638930B2Oct 28, 2003
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC1 citations63
ALMAC DISCOVERY LTD
2 patentsHEWLETT PACKARD DEVELOPMENT CO
1 patentMERCK SHARP
1 patentPLANTRONICS
1 patentLEWIS HUW DAVID
1 patentMERCK SHARPE & DOHME LTD
1 patentZHANG LIXIN
1 patentShowing the top 50 of 75 patents by PatentIndex Score.